In our study, the absence of TLR2 impaired the proliferation and invasion of HPSCC cells, while TLR2 was elevated in HPSCC tumor tissue, and a high TLR2 level was indicative of poor clinical outcomes for HPSCC. The gene discussed is TLR2; the disease is neoplasm.